A House of Lords committee has urged the UK government to address the regulatory and supply problems caused by the Northern Ireland Protocol, including the potential for regulatory divergence between Great Britain and the EU, the need for different medicine packs for Great Britain and Northern Ireland, and whether medicines should be removed from the scope of the protocol altogether.
Medicines ‘Must Not Fall Off The Radar’ In Northern Ireland Protocol Talks
As heated discussions continue on the future of the protocol that keeps Northern Ireland within the EU’s single market, the UK government has been urged to ensure concerns over medicines supply are addressed before “rushing to get a deal done.”
